FHTX (Foghorn Therapeutics, Inc.) Rasio rega marang prakiraan pendapatan

The high scientific standing of Foghorn Therapeutics (FHTX) in chromatin biology ensures market confidence. The future P/S multiple valuation on GURU.Markets captures the dynamics of this demand, where the 1.10 indicator reflects the asset's status. Growth is supported by innovations in gene modulation for blood therapies and production optimization via external plants in Massachusetts.

Foghorn Therapeutics Inc. - Prakiraan rega marang pendapatan FHTX (periode 04.07.2022 - 14.11.2026)

FHTX (foghorntx.com): rincian analitis lan laporan miturut indikator

- rega saiki lan proyeksi nilai saham:

Rega saham Foghorn Therapeutics Inc.|FHTX - Bagan tingkat prakiraan

- indikator valuasi pasar bisnis:

Nilai pasar Foghorn Therapeutics Inc.|FHTX - Total Nilai Perusahaan

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Foghorn Therapeutics|FHTX - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku foghorntx.com|FHTX - Nilai Agregat Aset

- data utang lan likuiditas:

Utang marang Ekuitas Foghorn Therapeutics|FHTX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Foghorn Therapeutics Inc.|FHTX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Foghorn Therapeutics Inc.|FHTX - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Foghorn Therapeutics|Indikator likuiditas cepet foghorntx.com

- rincian asil keuangan lan kelipatan valuasi:

FHTX - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Foghorn Therapeutics|FHTX - Nilai perusahaan marang bathi resik|Pangali Forward P/E Foghorn Therapeutics Inc.|FHTX - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Foghorn Therapeutics Inc.|FHTX - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Foghorn Therapeutics|FHTX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan foghorntx.com|FHTX - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Foghorn Therapeutics

- data pendapatan lan penerimaan dodolan:

FHTX - Total pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan Foghorn Therapeutics Inc.|FHTX - Multiplikator P/S|Multiplikator forward rega marang pendapatan Foghorn Therapeutics Inc.

Ringkesan analisis perusahaan:FHTX (Foghorn)

Assessing the investment reliability of equity assets begins with an analysis of the ratio of business market value to expected revenue. This metric measures the capitalization multiple relative to projected sales, which, in the case of Foghorn Therapeutics (FHTX) and its outsourcing of clinical trials, allows for the offsetting of operating expenses and the evaluation of genetic research potential via the projected P/S value.

Analisis pesaing Foghorn Therapeutics

Multiplikator Forward P/S TGTX (TG Therapeutics)|ACLX (Arcellx Inc) - Rega mangsa ngarep marang pendapatan|IRON - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Syndax Corp|KURA: Multiplikator Forward P/S|Prakiraan rega marang pendapatan adctherapeutics.com ADCT|VOR (Vor Biopharma) - Multiplikator Forward P/S|NKTX: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Coeptis Therapeutics (COEP)|ATNM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Estrella Immunopharma ESLA|Rega forward marang dodolan CASI|MRKR - Rasio rega marang prakiraan pendapatan|INAB (IN8bio Inc.) - Kapitalisasi marang prakiraan pendapatan|ERNA (eternatx.com) - Multiplikator forward rega marang pendapatan|GT Biopharma Corporation - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan APTO|BPTH (biopathholdings.com) - Rasio rega marang pendapatan sing dikarepake|Multiplikator Forward P/S MEIP|VINC (vincerx.com) - Rega forward marang dodolan